As cellular plasticity has been suggested to create therapeutic vulnerability in the cell proliferation pathway based on the “go or grow” principle 50, future studies may determine whether S6K1 is involved in regulating the “go or grow” decisions in models of cellular plasticity and tumor heterogeneity. The gene discussed is RPS6KB1; the disease is neoplasm.